Review

Apigenin and Hypertension: A Review of Natural Sources, Pharmacodynamic and Pharmacokinetic Evidence.

Mohammed Ajebli M. Hebi D. Ousaaid M. Akdad Zakariae Mankour T. Khouya B. Moukafih A. El Kartouti M. Eddouks

Oct 2026 · Pharmacology · pp. 1 · 0 citations

Medicine

TL;DR

APG emerges as a promising supplementary compound for hypertension management, combining vascular, molecular, and microbiome-mediated mechanisms with a strong safety margin.

DOI PubMed Semantic Scholar

View source

Similar papers

Review Oct 2026

The Therapeutic Potential of Berberine in Treating Diabetes and Its Complications: Molecular Mechanisms and Future Perspectives.

Diabetes mellitus (DM), a chronic metabolic disorder characterized by persistent hyperglycemia, poses a significant global health burden. Berberine (BBR), a natural isoquinoline alkaloid derived from medicinal plants such as Coptidis Rhizoma, has shown therapeutic promise for DM and its complications. Preclinical and c...

Yi-Le Liao, Yu Gui, Tong-Yi Li et al. · The American Journal of Chin... · 0 citations

Open access Sep 2026

Cannabinoids in Diabetes: Integrating Scientometric Trends with Mechanistic, Pharmacokinetic, and Clinical Evidence

Cannabinoid signaling has attracted increasing interest in diabetes because the endocannabinoid system regulates energy balance, glucose and lipid metabolism, inflammation, and tissue homeostasis. However, its therapeutic relevance remains uncertain. This study combined scientometric mapping with a critical synthesis o...

Isabella de Fátima Ramos de Almeida, Andressa Zago, Ariane Krause Padilha Lorenzett et al. · Future Pharmacology · 0 citations

Review Open access Sep 2026

A review bridging pharmacokinetics, preclinical data, and human evidence on curcuminoids in cardiovascular disease

Curcumin, the major curcuminoid of turmeric (Curcuma longa L.), has attracted sustained interest as a nutraceutical with pleiotropic anti-inflammatory, antioxidant, and vascular actions. However, extrapolating experimental in vitro findings to cardiovascular outcomes in humans is challenged by low aqueous solubility, c...

Katarzyna Zolnik, A. Mogielnicki, B. Kalaska · Frontiers in Pharmacology · 0 citations

Review Sep 2026

Coumarins in hypertension management: from vascular signaling pathways to clinical perspectives.

This review aimed to critically synthesize current evidence on the role of coumarins in hypertension management, integrating mechanistic insights, preclinical findings, pharmacokinetic considerations, and available clinical data.

Y. Mustafa · Hypertension Research · 0 citations

Review Open access Aug 2026

Multitarget Regulatory Mechanisms and Research Advances of Plant-Derived Bioactive Ingredients in Hypertension Prevention and Management.

This review systematically examines the mechanisms of major PDBIs in hypertension, focusing on their regulation of vascular function, renin-angiotensin-aldosterone system and sympathetic nervous system, water-salt homeostasis, and target organ protection.

Qiqi Deng, Yonglin Zhang, Jing Pan et al. · Phytotherapy Research · 1 citation

Review Oct 2026

Therapeutic Potential of Flavonoids and Their Metabolites in Hyperlipidaemia: Molecular Mechanisms, Bioavailability and Clinical Perspectives.

Hyperlipidaemia is a major modifiable risk factor for cardiovascular disease and remains a global health concern. Although conventional lipid-lowering drugs are effective, their long-term use is often associated with adverse effects, prompting interest in safer dietary alternatives. Flavonoids, such as quercetin, narin...

Shankul Kumar, A. Patel, Vedant Kumar Prajapati et al. · Current pharmaceutical desig... · 0 citations